Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.11.18 (
MAP
)
7,412
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Irregular mitochondria structure and reduced ATP in some patients with IBD suggest that metabolic stress contributes to disease. Loss-of-function mutation in the nucleotide-binding oligomerization domain (NOD)-2 gene is a major susceptibility trait for IBD. Hence, we assessed if loss of
NOD2
further impairs the epithelial barrier function instigated by disruption of mitochondrial ATP synthesis via the hydrogen ionophore dinitrophenol (DNP). NOD2 protein (virtually undetectable in epithelia under basal conditions) was increased in T84 (human colon cell line) cells treated with noninvasive
Escherichia coli
+ DNP (16 h). Increased intracellular bacteria in wild-type (WT) and
NOD2
knockdown (KD) cells and colonoids from
NOD2
-/-
mice were mediated by reactive oxygen species (ROS) and the MAPK ERK1/2 pathways as determined by cotreatment with the antioxidant mitoTEMPO and the ERK inhibitor U0126: ROS was upstream of ERK1/2 activation. Despite increased
E. coli
in DNP-treated
NOD2
KD compared with WT cells, there were no differences in the internalization of fluorescent inert beads or dead
E. coli
particles. This suggests that lack of killing in the
NOD2
KD cells was responsible for the increased numbers of viable intracellular bacteria; a conclusion supported by evidence of reduced autophagy in
NOD2
KD T84 epithelia. Thus, in a two-hit hypothesis, decreased barrier function due to dysfunctional mitochondrial is amplified by lack of
NOD2
in transporting enterocytes: subsequently, greater numbers of bacteria entering the mucosa would be a significant inflammatory threat especially since individuals with
NOD2
mutations have compromised macrophage and Paneth cell responses to bacteria.
NEW & NOTEWORTHY
Increased internalization of bacteria by epithelia with dysfunctional mitochondria (reduced ATP) is potentiated if the cells lack
nucleotide-binding oligomerization domain 2
(
NOD2
), mutations in which are inflammatory bowel disease-susceptibility traits. Uptake of bacteria was dependent on reactive oxygen species and
MAP
-kinase activity, and the increased viable intracellular bacteria in
NOD2
-/-
cells likely reflect a reduced ability to recognize and kill bacteria. Thus a significant barrier defect occurs with
NOD2
deficiency in conjunction with metabolic stress that could contribute to inflammation.
...
PMID:Absence of the NOD2 protein renders epithelia more susceptible to barrier dysfunction due to mitochondrial dysfunction. 2845 Feb 77